The antidepressant efficacy and side effect profile of a fixed dose of 20 mg/day of fluoxetine, a specific serotonin reuptake inhibitor, were compared to those of amitriptyline. Fifty-eight patients with DSM-III-R depression were randomly assigned to receive either fluoxetine or amitriptyline. Fifty-six patients (fluoxetine N = 23, amitriptyline N = 23) completed the 6 week study. Comparable antidepressant efficacy was demonstrated for the two drugs. Patients taking fluoxetine reported less side-effects than those taking amitriptyline.
References
1.
LembergerLFullerRWZerbeRL.Use of specific serotonin uptake inhibitors as antidepressants. Clinical Neuropharmacology1985; 8:299–317.
2.
WongDBymasterFPHorngJSMolloyBB.A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethyl phenoxy)-N-methyl-3-phenyl propylamine. Journal of Pharmacology and Experimental Therapeutics1975; 193:804–811.
3.
SchmidtMJFullerRWWongDT.Fluoxetine, a highly selective serotonin reuptake inhibitor: a review of preclinical studies. British Journal of Psychiatry1988; 153:(Supplement 3), 40–46.
4.
HallJ.Fluoxetine: Efficacy against placebo and by dose — an overview. British Journal of Psychiatry1988; 153:(Supplement 3), 59–63.
5.
LevineSDeoRMahadevanK.A comparative trial of a new antidepressant: fluoxetine. British Journal of Psychiatry1987; 150:653–655.
6.
YoungJPRColemanALaderMH.A controlled comparison of fluoxetine and amitriptyline in depressed outpatients. British Journal of Psychiatry1987; 151:337–340.
7.
BremnerJ.Fluoxetine in depressed patients: a comparison with imipramine. Journal of Clinical Psychiatry1984; 45:414–419.
8.
CohnJBWilcoxC.A comparison of fluoxetine, imipramine and placebo in patients with major depressive disorders. Journal of Clinical Psychiatry1985; 46:26–31.
9.
FeighnerJPBoyerWFMeridethCHHendricksonG.A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression. International Clinical Psychopharmacology1989; 4:127–134.
10.
ChouinardG.A double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorder. Journal of Clinical Psychiatry1985; 46:32–37.
11.
MannaVMartucciNAgnoliA.Double-blind controlled study on the clinical efficacy and safety of fluoxetine versus clomipramine in the treatment of major depressive disorders. International Clinical Psychopharmacology1989; 4 (Supplement 1):81–88.
12.
RopertRBouchardJMCaroliFCotinMDanicCBarbierJETalgornLLeroyJPRigalJBinouxFDelpechJDelcourtT.Fluoxetine versus clomipramine in major depressive disorders. International Clinical Psychopharmacology1989; 4:89–95.
13.
GinestetDAlbyJMBesanconGCarrierGCordierBDegiovanniADufourHFerreriMLegerLMoronPPelletJPerivierESingerLUlliacG.Fluoxetine in endogenous depression and melancholia versus clomipramine. International Clinical Psychopharmacology1989; 4:37–40.
14.
CooperGL.The safety of fluoxetine — an update. British Journal of Psychiatry. 1988; 153:(Supplement 3), 77–86.
15.
FawcettJZajeckaJMKravitzHMEdwardsJJeffriesHScorzaE.Fluoxetine versus amitriptyline in adult outpatients with major depression. Current Therapeutic Research1989; 45:821–832.
16.
FeighnerJP.A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder. Journal of Clinical Psychiatry1985; 46:369–372.
17.
MascoHLSheetzMS.Double-blind comparison of fluoxetine and amitriptyline in the treatment of major depressive illness. Advances in Therapy1985; 2:275–284.
18.
LaakmannGBlaschkeDEngelRSchwarzA.Fluoxetine v. Amitriptyline in Treatment of Depressed Outpatients. British Journal of Psychiatry1988; 153 (suppl 3):64–68.
19.
AlmaturaACPercudaniMGuercettiGInvernizziG.Efficacy and tolerability of fluoxetine in the elderly: a double-blind study versus amitriptyline. International Clinical Psychopharmacology1989; 4 (suppl 1):103–106.
20.
JuddFK.Preliminary report of a double-blind study comparing fluoxetine and amitriptyline in the treatment of depression. In: Recent Advances in the Treatment of Depression. Proceedings from a symposium in Hong Kong. JAMA SE Asia (Suppl)6 (4) 1991.
21.
HamiltonM.Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology1967; 6:278–296.
22.
CarrollBJFeinbergMSmousePERawsonSGGredenJF.The Carroll Rating Scale for Depression I. Development, Reliability and Validation. British Journal of Psychiatry1981; 138: 194–200.
23.
TeicherMHGlodCColeJO.Emergence of intense suicidal pre-occupation during fluoxetine treatment. American Journal of Psychiatry1990; 147:207–10.
24.
MasandPGuptaSDewanM.Suicidal ideation related to fluoxetine treatment. New England Journal of Medicine1991; 324:420.
25.
ClarkCDownieCC.A method for the rapid determination of the number of patients to include in a controlled clinical trial. Lancet1966; 2:1357–1358.
26.
BeasleyCMDornseifBEBosomworthJCSaylerMERampeyAHHeiligensteinJHThompsonVLMurphyDJMaricaDN.Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal1991; 303:685–692.
